Lynn Tetrault

Filings by Lynn Tetrault span 2 companies, the busiest being Neogenomics Inc and Rhythm Pharmaceuticals, Inc. Between 9 June 2026 and 22 June 2026, the trades on record add up to 3 filings.

No open-market purchase or sale appears among the filings, only grants, plan transactions and other operations. Compensation-driven entries like these are tracked, but they say little about how insiders judge the share price.

Most recently, on 22 June 2026, the filings show a transaction worth €3.1M in Rhythm Pharmaceuticals, Inc. The median gap between trade and publication is zero days: most filings appear on the same day. US insiders must file a Form 4 within two business days of a trade. Every figure here comes from the filings published by SEC (Form 4) and describes the past, not future prices; it is not investment advice.